The Role of Lipoxin A4 in Endometrial Biology and Endometriosis

Overview

Journal Mucosal Immunol

Publisher Elsevier

Specialty Allergy & Immunology

Date 2013 Mar 15

PMID 23485944

Citations 16

Authors

G O Canny

B A Lessey

Affiliations

Soon will be listed here.

Abstract

Lipoxin A4 (LXA4), an endogenous anti-inflammatory and immunomodulatory mediator studied in many disease states, is recently appreciated as a potentially significant player in the endometrium. This eicosanoid, synthesized from arachidonic acid via the action of lipoxygenase enzymes, is likely regulated in endometrial tissue during the menstrual cycle. Recent studies revealed that LXA4 acts as an estrogen receptor agonist in endometrial epithelial cells, antagonizing some estrogen-mediated activities in a manner similar to the weak estrogen estriol, with which it shares structural similarity. LXA4 may also be an anti-inflammatory molecule in the endometrium, though its precise function in various physiological and pathological scenarios remains to be determined. The expression patterns for LXA4 and its receptor in the female reproductive tract suggest a role in pregnancy. The present review provides an oversight of its known and putative roles in the context of immuno-endocrine crosstalk. Endometriosis, a common inflammatory condition and a major cause of infertility and pain, is currently treated by surgery or anti-hormone therapies that are contraceptive and associated with undesirable side effects. LXA4 may represent a potential therapeutic and further research to elucidate its function in endometrial tissue and the peritoneal cavity will undoubtedly provide valuable insights.

Citing Articles

Impact of Selected Eicosanoids in Normal and Pathological Pregnancies.

Szczuko M, Golanska J, Palma J, Zietek M J Clin Med. 2023; 12(18).

PMID: 37762934 PMC: 10532391. DOI: 10.3390/jcm12185995.

The Role of Dietary Fats in the Development and Treatment of Endometriosis.

Marcinkowska A, Gornicka M Life (Basel). 2023; 13(3).

PMID: 36983810 PMC: 10058497. DOI: 10.3390/life13030654.

Combined Application of Exosomes and FPR2 Agonist LXA4 in Controlling Fetal Membrane Inflammation and Promoting Fetal Membrane Tissue Repair.

Huang X, Liao J, Feng F, Chen S, Liao E, Li D Reprod Sci. 2022; 30(6):1979-1993.

PMID: 36525236 DOI: 10.1007/s43032-022-01148-x.

The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression.

Liotti F, Marotta M, Melillo R, Prevete N Cancers (Basel). 2022; 14(14).

PMID: 35884394 PMC: 9316558. DOI: 10.3390/cancers14143333.

Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolving Responses.

Luo S, Chiu T, Chen W, Wang C Int J Mol Sci. 2021; 22(16).

PMID: 34445474 PMC: 8395901. DOI: 10.3390/ijms22168768.

References

Wang S, Hu K, Seamon K, Mani V, Chen Y, Gronert K . Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea. FASEB J. 2011; 26(4):1506-16. PMC: 3316908. DOI: 10.1096/fj.11-198036. View

King A, Critchley H . Oestrogen and progesterone regulation of inflammatory processes in the human endometrium. J Steroid Biochem Mol Biol. 2010; 120(2-3):116-26. DOI: 10.1016/j.jsbmb.2010.01.003. View

Tsuji I, Ami K, Miyazaki A, Hujinami N, Hoshiai H . Benefit of diagnostic laparoscopy for patients with unexplained infertility and normal hysterosalpingography findings. Tohoku J Exp Med. 2009; 219(1):39-42. DOI: 10.1620/tjem.219.39. View

Critchley H, Tong S, Cameron S, Drudy T, Kelly R, Baird D . Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo. J Reprod Fertil. 1999; 115(2):389-95. DOI: 10.1530/jrf.0.1150389. View

Waechter V, Schmid M, Herova M, Weber A, Gunther V, Marti-Jaun J . Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages. J Immunol. 2012; 188(4):1856-67. DOI: 10.4049/jimmunol.1101788. View

Hedqvist P, Raud J, Palmertz U, Haeggstrom J, Nicolaou K, Dahlen S . Lipoxin A4 inhibits leukotriene B4-induced inflammation in the hamster cheek pouch. Acta Physiol Scand. 1989; 137(4):571-2. DOI: 10.1111/j.1748-1716.1989.tb08805.x. View

Lessey B, Wahawisan R, Gorell T . Hormonal regulation of cytoplasmic estrogen and progesterone receptors in the beagle uterus and oviduct. Mol Cell Endocrinol. 1981; 21(2):171-80. DOI: 10.1016/0303-7207(81)90054-x. View

Russell R, Gori I, Pellegrini C, Kumar R, Achtari C, Canny G . Lipoxin A4 is a novel estrogen receptor modulator. FASEB J. 2011; 25(12):4326-37. DOI: 10.1096/fj.11-187658. View

Guerin L, Prins J, Robertson S . Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?. Hum Reprod Update. 2009; 15(5):517-35. PMC: 2725755. DOI: 10.1093/humupd/dmp004. View

10.

Masuzawa H, Badokhon N, Nakayama K, Konishi I, Nikaido T, Fujii S . Failure of down-regulation of estrogen receptors and progesterone receptors after medroxyprogesterone acetate administration for endometrial hyperplasias. Cancer. 1994; 74(8):2321-8. DOI: 10.1002/1097-0142(19941015)74:8<2321::aid-cncr2820740817>3.0.co;2-6. View

11.

May K, Villar J, Kirtley S, Kennedy S, Becker C . Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Hum Reprod Update. 2011; 17(5):637-53. DOI: 10.1093/humupd/dmr013. View

12.

Das N, Wang J, Dey S . Uterine preparation for implantation in the mouse is associated with coordinate expression of estrogen-responsive finger protein and estrogen receptor. Mol Reprod Dev. 1997; 46(4):499-506. DOI: 10.1002/(SICI)1098-2795(199704)46:4<499::AID-MRD8>3.0.CO;2-J. View

13.

Bukulmez O, Hardy D, Carr B, Word R, Mendelson C . Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology. 2007; 149(3):1190-204. PMC: 2275353. DOI: 10.1210/en.2007-0665. View

14.

Chuang P, Lin Y, Wu M, Wing L, Shoji Y, Tsai S . Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis. Am J Pathol. 2009; 176(2):850-60. PMC: 2808090. DOI: 10.2353/ajpath.2010.090551. View

15.

Maybin J, Critchley H, Jabbour H . Inflammatory pathways in endometrial disorders. Mol Cell Endocrinol. 2010; 335(1):42-51. DOI: 10.1016/j.mce.2010.08.006. View

16.

Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A . Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology. 2000; 11(3):315-9. DOI: 10.1097/00001648-200005000-00015. View

17.

Matsuzaki S, Fukaya T, Uehara S, Murakami T, Sasano H, Yajima A . Characterization of messenger RNA expression of estrogen receptor-alpha and -beta in patients with ovarian endometriosis. Fertil Steril. 2000; 73(6):1219-25. DOI: 10.1016/s0015-0282(00)00527-6. View

18.

Gori I, Pellegrini C, Staedler D, Russell R, Jan C, Canny G . Tumor necrosis factor-α activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor α. Mol Cell Endocrinol. 2011; 345(1-2):27-37. DOI: 10.1016/j.mce.2011.06.043. View

19.

Serhan C . Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2006; 25:101-37. DOI: 10.1146/annurev.immunol.25.022106.141647. View

20.

Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B . Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol. 2009; 175(2):547-56. PMC: 2716955. DOI: 10.2353/ajpath.2009.081011. View